Hans Loibner,Manfred Schuster,Evelyne Janzek-Hawlat,Susanne Wiederkum,Bernhard Peball,Stefan Stranner,Oliver Mutschlechner,Franz Groiss,Ruth Ladenstein,Holger Lode
申请号：
US14409161
公开号：
US09777068B2
申请日:
2012.07.31
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.
